Ukko
PrivateLast Round
Series C
Jan 8, 2026
Total Funding Raised
$92.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ukko is a biotechnology company that develops immunity-boosting proteins and novel immunotherapies aimed at treating food allergies and immune-mediated conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ukko Comparables
Compare Ukko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IgGenix | 75% | |
| Nestlé | 69% | |
| Biolojic Design | 65% | |
Ukko Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 8, 2026 | ||||
| Series B | Jan 27, 2021 | ||||
| Series A | Jul 24, 2017 |
Key People
Founding team and executive leadership
Ukko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fall Line Capital | Series C, Series B |
| Israel Biotech Fund | Series C |
| Skyviews Life Science | Series B |
| TIME Ventures | Series B |
| Khosla Ventures | Series C, Series A, Series B |
| Innovation Endeavors | Series A, Series B |
| PeakBridge | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 108% MoM, reaching 2.5K.
- Jan 27, 2021
$40M round led by Leaps by Bayer.
Ukko Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ukko's valuation, stock price, and market status.